Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)

Clinical trial NCT07147114 · RECRUITING

Trial details

NCT number: NCT07147114
Sponsor: Gachon University Gil Medical Center
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Combined Pre- and Post-capillary Pulmonary Hypertension CpcPH HFmrEF HFpEF Group 2 Pulmonary Hypertension

Start date: 2025-11-24
Primary completion: 2027-09-30
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.